Clinical Trials on CNS Vasculitis in Australia
Total 189 results
-
Royal Brisbane and Women's HospitalUnknown
-
Varian, a Siemens Healthineers CompanyRecruitingBrain Metastases | CNS Neoplasm | CNS Disorder, IntracranialUnited States, Australia
-
University Hospital HeidelbergGerman Cancer Research CenterRecruitingSolid Tumor | CNS TumorFrance, Germany, Australia, Austria, Sweden, Netherlands, Switzerland
-
Novartis PharmaceuticalsRecruitingPolymyalgia RheumaticaAustralia
-
Merck KGaA, Darmstadt, GermanyMerck Serono Australia Pty LtdCompleted
-
Cambridge University Hospitals NHS Foundation TrustUniversity of Pennsylvania; Roche Pharma AG; Genentech, Inc.; Arthritis Research...CompletedMicroscopic Polyangiitis | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | Wegener GranulomatosisUnited States, Canada, United Kingdom, Sweden, New Zealand, Ireland, Australia, Italy, Czechia, Japan
-
Dr David ZieglerEngeneic Pty LimitedTerminatedSolid Tumours | CNS TumoursAustralia
-
ChemoCentryxCompletedA Phase 3 Clinical Trial of CCX168 (Avacopan) in Patients With ANCA-Associated Vasculitis (ADVOCATE)ANCA-Associated VasculitisUnited States, Australia, Belgium, Canada, France, Italy, Japan, Netherlands, Spain, United Kingdom, Austria, Czechia, Denmark, Germany, Hungary, Ireland, New Zealand, Norway, Sweden, Switzerland
-
Royal North Shore HospitalCompleted
-
Pipeline Therapeutics, Inc.Completed
-
Pfenex, IncCompleted
-
Medical University InnsbruckRecruitingEosinophilic Asthma | Eosinophilic Pneumonia | EGPA - Eosinophilic Granulomatosis With Polyangiitis | Samter Triad | HES - Hypereosinophilic SyndromeAustria
-
Syneos HealthDr. Reddy's Laboratories LimitedCompletedRheumatoid Arthritis | Giant Cell ArteritisNew Zealand, Australia, India
-
GlaxoSmithKlineCompletedMultiple Sclerosis, Relapsing-RemittingAustralia
-
GlaxoSmithKlineCompleted
-
Medical University of ViennaCompleted
-
Alpine Immune Sciences, Inc.RecruitingLupus Nephritis | Immunoglobulin A Nephropathy | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | Membranous NephropathyUnited States, Australia, Korea, Republic of, Austria, Norway, Spain, United Kingdom
-
University of PennsylvaniaNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and other collaboratorsCompletedMicroscopic Polyangiitis (MPA) | Granulomatosis With Polyangiitis (Wegener's) (GPA)United States, Belgium, France, United Kingdom, Denmark, Canada, Japan, Australia, New Zealand, Sweden, Czechia, Italy, Greece, Mexico, Norway
-
Human Genome Sciences Inc., a GSK CompanyGlaxoSmithKlineCompletedVasculitisUnited States, Australia, France, Spain, Italy, Peru, Belgium, Canada, Germany, Romania, Mexico, United Kingdom, Hungary, Ireland, Poland, Switzerland, Czechia, Russian Federation, Norway, Sweden
-
University of MelbourneActive, not recruitingMultiple SclerosisAustralia
-
Monash UniversityEnrolling by invitationMultiple Sclerosis | Adherence, MedicationAustralia
-
GeNeuro Australia PTY LtdCompleted
-
GlaxoSmithKlineCompletedMultiple Sclerosis, Relapsing-RemittingAustralia
-
Melbourne HealthEastern HealthCompletedMultiple Sclerosis | TremorAustralia
-
GlaxoSmithKlineCompletedMultiple Sclerosis, Relapsing-RemittingAustralia
-
GlaxoSmithKlineCompletedMultiple Sclerosis, Relapsing-RemittingAustralia
-
Vienna Institute for Research in Ocular SurgeryRecruitingMap Dot Fingerprint DystrophyAustria
-
BayerCompletedMultiple Sclerosis | Positron-Emission TomographyAustralia, Sweden
-
GlaxoSmithKlineRecruitingEosinophilic Granulomatosis With PolyangiitisCanada, France, Italy, Spain, Belgium, Korea, Republic of, United States, Japan, China, Czechia, Hungary, Israel, Portugal, Poland, Netherlands, United Kingdom, Austria, Argentina, Australia, Brazil, Germany, Sweden
-
Innate ImmunotherapeuticsSyneos HealthCompletedSecondary Progressive Multiple SclerosisNew Zealand, Australia
-
Novartis PharmaceuticalsRecruitingRelapsing Multiple SclerosisAustralia
-
BiogenTerminatedRelapsing Remitting Multiple SclerosisAustralia
-
BiogenCompletedMultiple SclerosisUnited States, Australia, Austria, Canada
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisNew Zealand, Australia
-
Genzyme, a Sanofi CompanyTerminatedMultiple SclerosisUnited States, Australia, Austria, Belgium, Canada, Denmark, Germany, Italy, Netherlands, Spain, Sweden, Switzerland, United Kingdom
-
Novartis PharmaceuticalsCompletedRelapsing Forms of Multiple SclerosisAustralia, United States
-
GlaxoSmithKlineTerminatedGiant Cell ArteritisUnited States, Spain, Germany, Italy, Belgium, France, Netherlands, Australia, United Kingdom, Hungary, Poland, Bulgaria, New Zealand
-
Salzburger LandesklinikenEnrolling by invitation
-
Medical University of ViennaCompleted
-
Bristol-Myers SquibbWithdrawnGiant Cell ArteritisPoland, United States, Spain, France, Austria, Belgium, Italy, Romania, Switzerland, Germany, Greece, Netherlands, Australia, Denmark, United Kingdom, Ireland, Bulgaria, Canada, Estonia, Serbia, Sweden
-
Medical University of ViennaNational Bank of AustriaUnknownMultiple Sclerosis | FatigueAustria
-
Medical University of ViennaCompletedMultiple Sclerosis | M-healthAustria
-
University of OxfordAmerican College of Rheumatology; The European League Against Rheumatism (EULAR) and other collaboratorsUnknownGiant Cell Arteritis | Wegener's Granulomatosis | Microscopic Polyangiitis | Polyarteritis Nodosa | Takayasu Arteritis | Churg Strauss SyndromeKorea, Republic of, United States, Germany, Australia, Japan, Ireland, Belgium, Italy, Denmark, Slovenia, Switzerland, Canada, Argentina, Austria, China, Czech Republic, Egypt, Finland, France, Hungary, India, Mexico, Netherlands, New... and more
-
Medical University of GrazRecruitingMultiple SclerosisAustria
-
ChemoCentryxCompletedVasculitisFrance, United Kingdom, Germany, Belgium, Poland, Netherlands, Hungary, Austria, Sweden, Czechia
-
Novartis PharmaceuticalsRecruitingRelapsing Multiple SclerosisAustria
-
Novartis PharmaceuticalsCompletedMayzent (Siponimod) Onboarding of Secondary Progressive Multiple Sclerosis (SPMS) Patients With MSGoSecondary Progressive Multiple SclerosisAustralia
-
Medical University of ViennaUnknownMultiple Sclerosis | FatigueAustria